These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38201570)

  • 1. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation.
    Zimmerman JAO; Fang M; Pufall MA
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kδ inhibition potentiates glucocorticoids in B-lymphoblastic leukemia by decreasing receptor phosphorylation and enhancing gene regulation.
    Zimmerman JAO; Fang M; Pufall MA
    bioRxiv; 2023 Aug; ():. PubMed ID: 36798391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
    Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
    Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes.
    Blind RD; Garabedian MJ
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):150-7. PubMed ID: 18304804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor phosphorylation differentially affects target gene expression.
    Chen W; Dang T; Blind RD; Wang Z; Cavasotto CN; Hittelman AB; Rogatsky I; Logan SK; Garabedian MJ
    Mol Endocrinol; 2008 Aug; 22(8):1754-66. PubMed ID: 18483179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idelalisib: A Novel PI3Kδ Inhibitor for Chronic Lymphocytic Leukemia.
    Shah A; Mangaonkar A
    Ann Pharmacother; 2015 Oct; 49(10):1162-70. PubMed ID: 26185276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14-3-3.
    Habib T; Sadoun A; Nader N; Suzuki S; Liu W; Jithesh PV; Kino T
    Mol Cell Endocrinol; 2017 Jan; 439():431-443. PubMed ID: 27717743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL.
    Adam E; Kim HN; Gang EJ; Schnair C; Lee S; Lee S; Khazal S; Kosoyan O; Konopleva M; Parekh C; Bhojwani D; Wayne AS; Abdel-Azim H; Heisterkamp N; Kim YM
    Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28891959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
    Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
    J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.
    Lynch JT; Rajendran R; Xenaki G; Berrou I; Demonacos C; Krstic-Demonacos M
    Mol Cancer; 2010 Feb; 9():38. PubMed ID: 20156337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by
    Li J; Hlavka-Zhang J; Shrimp JH; Piper C; Dupéré-Richér D; Roth JS; Jing D; Casellas Román HL; Troche C; Swaroop A; Kulis M; Oyer JA; Will CM; Shen M; Riva A; Bennett RL; Ferrando AA; Hall MD; Lock RB; Licht JD
    Cancer Discov; 2022 Jan; 12(1):186-203. PubMed ID: 34417224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia.
    Wang X; Zhang X; Li BS; Zhai X; Yang Z; Ding LX; Wang H; Liang C; Zhu W; Ding J; Meng LH
    Oncotarget; 2014 Nov; 5(21):10732-44. PubMed ID: 25313141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
    He LX; Yang L; Liu T; Li YN; Huang TX; Zhang LL; Luo J; Liu CT
    Respir Res; 2023 Mar; 24(1):90. PubMed ID: 36949482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
    Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.
    Palazzo A; Herter S; Grosmaire L; Jones R; Frey CR; Limani F; Bacac M; Umana P; Oldham RJ; Marshall MJE; Cox KL; Turaj AH; Cragg MS; Klein C; Carter MJ; Tannheimer S
    J Immunol; 2018 Apr; 200(7):2304-2312. PubMed ID: 29453281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling.
    Kuo T; Lew MJ; Mayba O; Harris CA; Speed TP; Wang JC
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11160-5. PubMed ID: 22733784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All).
    Bortolozzi R; Mattiuzzo E; Trentin L; Accordi B; Basso G; Viola G
    Biochem Pharmacol; 2018 Jul; 153():230-241. PubMed ID: 29408328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.